Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 9/20 | 0.45 |
| ▸ | NPY1R | P25929 | 5/20 | 0.45 |
| ▸ | NPY2R | P49146 | 4/20 | 0.45 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.45 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.43 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.43 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.43 |
| ▸ | TERT | O14746 | 1/20 | 0.42 |
| ▸ | OPRL1 | P41146 | 3/20 | 0.41 |
| ▸ | TLR2 | O60603 | 1/20 | 0.41 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.40 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30819414 | 0.96 | GNAI3 (0.46) | NPY4RNPY1RNPY2RNPY5RGNAI3 | |
| SCHEMBL30254242 | 0.90 | GNAI3 (0.43) | NPY4RNPY1RNPY2RNPY5RGNAI3 | |
| SCHEMBL22133166 | 0.89 | TLR2 (0.44) | NPY4RNPY1RNPY2RNPY5RTLR2 | |
| SCHEMBL31678957 | 0.89 | TERT (0.50) | GNAI3GNAO1GNAI1TERTTLR2 | |
| SCHEMBL31691755 | 0.88 | NPY4R (0.44) | NPY4RNPY1RNPY2RNPY5RGNAI3 | |
| SCHEMBL31406583 | 0.88 | NOD1 (0.47) | NPY4RNPY1RNPY2RNPY5RGNAI3 | |
| SCHEMBL22342260 | 0.88 | TLR2 (0.43) | NPY4RNPY1RNPY2RNPY5RTLR2 | |
| SCHEMBL30497050 | 0.88 | NOD1 (0.47) | NPY4RNPY1RNPY2RNPY5RGNAI3 | |
| SCHEMBL16409463 | 0.88 | NPY4R (0.48) | NPY4RNPY1RNPY2RNPY5ROPRL1 | |
| SCHEMBL17955405 | 0.88 | NPY4R (0.46) | NPY4RNPY1RNPY2RNPY5RGNAI3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230416329-A1 | A PEPTIDE WITH DISULFIDE BONDS AND INHIBITORY ACTIVITY AGAINST SERINE PROTEASES, DERIVED HYBRID PEPTIDES THEREOF, AND USES THEREOF | INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2023-12-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230416329-A1 | A PEPTIDE WITH DISULFIDE BONDS AND INHIBITORY ACTIVITY AGAINST SERINE PROTEASES, DERIVED HYBRID PEPTIDES THEREOF, AND USES THEREOF | VIP, SI, TMPRSS15 | NPY4R 1616/4885NPY1R 1934/4885NPY2R 2570/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.